MIF-1 Guide

What Is MIF-1 and Why Does Dosing Matter?

MIF-1 (Pro-Leu-Gly-NH2 (Melanocyte-inhibiting factor-1)) is a Neuropeptide, dopamine receptor modulator. Endogenous tripeptide derived from cleavage of oxytocin, produced primarily by the hypothalamus. Getting the dosage right is critical — too little may produce no measurable effect, while excessive amounts increase risk without proportional benefit.

The standard research dosage for MIF-1 has been established through preclinical studies and community protocols. This guide covers the evidence-backed dosing range, timing, and cycle structure.

What Is the Recommended MIF-1 Dosage?

The most widely used MIF-1 dosage is 1-10 mg, administered once daily via subcutaneous injection (poorly active orally).

Beginners should start at the lower end of this range and titrate upward only if needed. The half-life of MIF-1 is resistant to bloodstream metabolism; crosses blood-brain barrier, which directly determines how often you need to dose to maintain stable blood levels.

For MIF-1 specifically, the not established; short protocols in research cycle length is standard. Longer isn't always better — Neuropeptide, dopamine receptor modulator compounds require cycling to maintain receptor sensitivity.

When Should You Dose MIF-1?

With a half-life of resistant to bloodstream metabolism; crosses blood-brain barrier, timing your MIF-1 administration affects peak blood levels. Most protocols call for once daily.

For peptides administered before bed (common with GH-related compounds), the goal is to amplify the natural nocturnal growth hormone pulse. For healing peptides, proximity to the injury site via local injection can improve outcomes.

How Do You Reconstitute MIF-1?

MIF-1 typically comes as a lyophilized (freeze-dried) powder. Reconstitute with bacteriostatic water — never saline or sterile water, as BAC water contains 0.9% benzyl alcohol that prevents bacterial growth and extends shelf life to 4-6 weeks.

Use our peptide dosing calculator to determine the exact amount of BAC water to add based on your vial size and desired dose per injection.

How Long Should a MIF-1 Cycle Last?

Standard MIF-1 cycles run not established; short protocols in research. This timeframe is based on the compound's mechanism and the time needed to observe measurable effects.

Extensively studied in animal models showing antidepressant and nootropic effects through multiple neurotransmitter systems. Multiple peer-reviewed studies from 1980s-1990s. No human clinical trials.

What Side Effects Can Affect Dosing?

Limited human data. Inverted U-curve response — loses efficacy at very high doses. No serious adverse effects documented.

If side effects emerge, the first step is typically reducing the dose rather than discontinuing entirely. Most MIF-1-related side effects are dose-dependent.

How Does MIF-1 Dosing Change When Stacking?

Pairs with dopamine-enhancing compounds (L-DOPA) to amplify dopaminergic effects through allosteric modulation.

When stacking, some researchers reduce individual peptide doses by 20-30% since synergistic effects mean full doses of each aren't always necessary.

What Is the Bottom Line on MIF-1 Dosing?

Start at 1, dose once daily, and run cycles of not established; short protocols in research. Monitor your response and adjust within the established range.

Source matters — always use research-grade MIF-1 from vendors with third-party COA testing. Underdosed or contaminated products are the most common reason for poor results.

Related Reading

• MIF-1 Benefits
• MIF-1 Side Effects
• MIF-1 Stacking Guide
• MIF-1 Cycle Guide
• MIF-1 Research
• Dihexa Complete Guide

Frequently Asked Questions